Abstract Objective To compare the efficacy and safety of intravenous paracetamol with intramuscular tramadol hydrochloride as intrapartum analgesia in primigravida women during the active phase of labour. Design Prospective, single-blind, randomised controlled trial. Setting Labour ward of a tertiary care hospital in India. Population or Sample Primigravida women aged 18–30 years with term, singleton, vertex pregnancies in spontaneous active labour, meeting strict inclusion criteria. Methods A total of 9,945 women were randomised into two groups: Group 1 received 1000 mg intravenous paracetamol; Group 2 received 100 mg intramuscular tramadol. Pain was measured using the Visual Analogue Scale (VAS) at baseline, 10 minutes, and one hour post-intervention. Labour outcomes, maternal side effects, and neonatal parameters were recorded and analysed. Main Outcome Measures Reduction in VAS pain scores, duration and mode of delivery, maternal side effects, Apgar scores, neonatal respiratory status, and NICU admissions. Results Both medications effectively reduced labour pain. At one hour, the tramadol group showed significantly greater pain relief (VAS 4.70 ± 0.86 vs. 5.02 ± 0.78; p = 0.0063). However, the paracetamol group experienced fewer side effects, including significantly less vomiting (10% vs. 23%; p = 0.0222), and had better neonatal outcomes. Apgar scores at 1 and 5 minutes were significantly higher in the paracetamol group ( p = 0.0001 and p < 0.0001), with fewer cases of neonatal respiratory depression. Conclusions Intravenous paracetamol is a safe, effective, and accessible alternative to tramadol for labour analgesia, especially suited to low-resource settings due to its ease of use and favourable safety profile. Funding No funding was received for this study. Trial Registration Clinical Trials Registry – India (CTRI/2018/06/014589) Keywords Paracetamol, Tramadol, Labour analgesia, Intrapartum pain, Randomised controlled trial, Low-resource settings